Advances in imaging angiogenesis and inflammation in atherosclerosis
- PMID: 21331441
- PMCID: PMC3837423
- DOI: 10.1160/TH10-08-0562
Advances in imaging angiogenesis and inflammation in atherosclerosis
Abstract
Advances in imaging technology have provided powerful tools for dissecting the angiogenic and inflammatory aspects of atherosclerosis. Improved technology along with multi-modal approaches has expanded the utilisation of imaging. Recent advances provide the ability to better define structure and development of angiogenic vessels, identify relationships between inflammatory mediators and the vessel wall, validate biological effects of anti-inflammatory and anti-angiogenic drugs, delivery and/or targeting specific molecules to inflammatory regions of atherosclerotic plaques.
Figures




Comment in
-
More on advances in imaging angiogenesis and inflammation in atherosclerosis.Thromb Haemost. 2011 May;105(5):920-1. doi: 10.1160/TH11-02-0131. Epub 2011 Mar 24. Thromb Haemost. 2011. PMID: 21437350 No abstract available.
Similar articles
-
More on advances in imaging angiogenesis and inflammation in atherosclerosis.Thromb Haemost. 2011 May;105(5):920-1. doi: 10.1160/TH11-02-0131. Epub 2011 Mar 24. Thromb Haemost. 2011. PMID: 21437350 No abstract available.
-
Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54. doi: 10.1161/ATVBAHA.113.302963. Epub 2014 May 1. Arterioscler Thromb Vasc Biol. 2014. PMID: 24790139
-
Inflammation and atherosclerosis: what is on the horizon?Heart. 2020 Jan;106(1):80-85. doi: 10.1136/heartjnl-2018-314230. Heart. 2020. PMID: 31843811 Review. No abstract available.
-
Angiogenesis in the atherosclerotic plaque.Redox Biol. 2017 Aug;12:18-34. doi: 10.1016/j.redox.2017.01.007. Epub 2017 Feb 1. Redox Biol. 2017. PMID: 28212521 Free PMC article. Review.
-
Emerging anti-inflammatory therapies for atherosclerosis.Curr Pharm Des. 2013;19(33):5840-9. doi: 10.2174/13816128113199990351. Curr Pharm Des. 2013. PMID: 23438958 Review.
Cited by
-
Cilengitide Inhibits Neovascularization in a Rabbit Abdominal Aortic Plaque Model by Impairing the VEGF Signaling.Biomed Res Int. 2021 Nov 30;2021:5954757. doi: 10.1155/2021/5954757. eCollection 2021. Biomed Res Int. 2021. PMID: 34888383 Free PMC article.
-
DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice.PLoS One. 2024 Apr 18;19(4):e0302387. doi: 10.1371/journal.pone.0302387. eCollection 2024. PLoS One. 2024. PMID: 38635560 Free PMC article.
-
Importance of receptor-targeted systems in the battle against atherosclerosis.Curr Pharm Des. 2013;19(33):5897-903. doi: 10.2174/1381612811319330010. Curr Pharm Des. 2013. PMID: 23438961 Free PMC article. Review.
-
Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.Trends Cardiovasc Med. 2013 May;23(4):114-20. doi: 10.1016/j.tcm.2012.09.009. Epub 2013 Jan 11. Trends Cardiovasc Med. 2013. PMID: 23313168 Free PMC article. Review.
References
-
- Sadeghi MM. The pathobiology of the vessel wall: implications for imaging. J Nucl Cardiol. 2006;13:402–414. - PubMed
-
- Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109:II27–33. - PubMed
-
- Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519. - PubMed
-
- Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1:297–329. - PubMed
-
- Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005;4:3–8. - PubMed